Brett M. Lillie
Pfizer (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Chemical Synthesis and Reactions, Chemokine receptors and signaling, Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research
Most-Cited Works
- → Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor(2003)668 cited
- → Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection(2010)332 cited
- → Mild and Efficient DBU-Catalyzed Amidation of Cyanoacetates(2009)111 cited
- → DBU Catalysis of N,N′-Carbonyldiimidazole-Mediated Amidations(2009)92 cited
- → CP-481,715, a Potent and Selective CCR1 Antagonist with Potential Therapeutic Implications for Inflammatory Diseases(2003)89 cited
- → Development of an Efficient Pd-Catalyzed Coupling Process for Axitinib(2013)66 cited
- → Novel CCR1 antagonists with improved metabolic stability(2004)33 cited
- → Potent small molecule CCR1 antagonists(2004)25 cited
- → Sulfur Contamination Due to Quenching of Halogenation Reactions with Sodium Thiosulfate: Resolution of Process Problems via Improved Quench Protocols(2008)22 cited
- → The protection of ketones and aldehydes as 4-trimethylsilylmethyl-1,3-dioxolanes(1994)20 cited